Coty COTY
- Market cap
- $2.3B
- P/E
- 0.0×
Follow COTY
Target Price Range
Analyst price targets
Free account| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14.24 | 5.91 | 6.29 | 2.65 | 6.20 | 5.90 | 8.59 | 6.80 | 2.94 | 1.82 |
Analyst estimates 2027–2029 Powerpack |
Low Price
|
||
| 20.88 | 21.68 | 14.14 | 13.01 | 11.12 | 10.82 | 13.46 | 13.30 | 7.71 | 3.47 |
High Price
|
|||
| 22,000 | 20,000 | 19,000 | 18,260 | 11,430 | 11,012 | 11,350 | 11,791 | 11,636 | 11,335 |
Employees
|
|||
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Revenue/Emp
|
|||
| 7,650 | 6,842 | 6,288 | 4,718 | 4,630 | 5,304 | 5,554 | 6,118 | 5,893 | 5,807 |
Revenue
|
|||
| 60.42% | 60.27% | 60.26% | 57.79% | 59.79% | 63.52% | 63.87% | 64.39% | 64.84% | 62.89% |
Gross Margin
|
|||
| (658) | (394) | (3,945) | (1,468) | (240) | 427 | 705 | 205 | (345) | (610) |
EBT
|
|||
| (8.60%) | (5.77%) | (62.75%) | (31.11%) | (5.18%) | 8.05% | 12.69% | 3.34% | (5.85%) | (10.51%) |
EBT Margin
|
|||
| (398) | (128) | (3,770) | (1,003) | (205) | 268 | 523 | 109 | (350) | (590) |
Net Income
|
|||
| 555 | 737 | 736 | 717 | 585 | 516 | 427 | 421 | 420 | 482 |
Depreciation
|
|||
| 11.90 | 9.13 | 8.37 | 6.22 | 6.05 | 6.46 | 6.54 | 7.00 | 6.77 | 6.62 |
Revenue/Sh
|
|||
| (0.66) | (0.23) | (5.04) | (1.33) | (0.40) | 0.08 | 0.58 | 0.09 | (0.44) | (0.70) |
Earnings/Sh
|
|||
| 1.18 | 0.55 | 0.85 | (0.07) | 0.42 | 0.89 | 0.74 | 0.70 | 0.57 | 0.61 |
Cash Flow/Sh
|
|||
| (0.65) | (0.55) | (0.55) | (0.35) | (0.22) | (0.21) | (0.26) | (0.28) | (0.25) | (0.25) |
Capex/Sh
|
|||
| 0.52 | 0.01 | 0.30 | (0.42) | 0.20 | 0.67 | 0.47 | 0.42 | 0.32 | 0.36 |
Free CF/Sh
|
|||
| 14.50 | 11.81 | 6.11 | 4.25 | 4.00 | 4.08 | 4.71 | 4.59 | 4.27 | 3.60 |
Book Value/Sh
|
|||
| 643 | 750 | 751 | 759 | 765 | 821 | 849 | 874 | 871 | 877 |
Shares
|
|||
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 100.13 | 21.19 | 122.00 | 0.00 | 0.00 |
PE Ratio
|
|||
| 1.58 | 1.52 | 1.08 | 0.72 | 1.54 | 1.24 | 1.88 | 1.39 | 0.69 | 0.33 |
PS Ratio
|
|||
| 1.29 | 1.17 | 1.90 | 1.06 | 2.33 | 1.96 | 2.61 | 2.13 | 1.09 | 0.60 |
PB Ratio
|
|||
| 2.43 | 2.57 | 1.99 | 2.36 | 2.65 | 2.03 | 2.59 | 1.97 | 1.31 | 0.82 |
EV/Sales
|
|||
| 67.36 | (314.14) | 96.12 | (29.50) | 137.58 | 21.81 | 41.96 | 38.97 | 99.34 | (152.86) |
EV/FCF
|
|||
| 758 | 414 | 640 | (51) | 319 | 727 | 626 | 615 | 493 | 538 |
Op' Cash Flow
|
|||
| (421) | (410) | (413) | (267) | (170) | (174) | (223) | (245) | (215) | (220) |
Capex
|
|||
| 337 | 4 | 226 | (318) | 149 | 553 | 403 | 369 | 278 | 318 |
FCF
|
|||
| (222) | (393) | (204) | 2,909 | (632) | (884) | (685) | (638) | (585) | (623) |
Working Cap'
|
|||
| 7,137 | 7,524 | 7,664 | 8,080 | 5,425 | 4,432 | 4,236 | 3,845 | 3,959 | 3,048 |
Total Debt
|
|||
| 6,567 | 7,162 | 7,283 | 7,728 | 5,115 | 4,168 | 3,952 | 3,524 | 3,689 | 2,859 |
Net Debt
|
|||
| 9,318 | 8,855 | 4,593 | 3,229 | 3,062 | 3,346 | 3,997 | 4,012 | 3,719 | 3,162 |
Sh' Equity
|
|||
| (2.85%) | (0.75%) | (18.76%) | (5.88%) | (2.00%) | 0.47% | 4.00% | 0.62% | (3.18%) | (5.59%) |
ROA
|
|||
| (1.66%) | (0.61%) | (19.41%) | (7.05%) | (0.37%) | 2.00% | 4.27% | 4.53% | 2.03% | (0.85%) |
ROIC
|
|||
| (8.72%) | (1.86%) | (56.28%) | (25.91%) | (9.65%) | 1.91% | 13.48% | 1.90% | (9.86%) | (17.96%) |
ROE
|
|||
Coty (COTY) key facts
- Coty (COTY) is a Household & Personal Products company in the Consumer Defensive sector, listed on the New York Stock Exchange.
- Coty’s revenue for fiscal 2026 (year ended June 2026) was $5.8 billion, down 1.46% from fiscal 2025.
- As of September 25, 2026, COTY traded at $2.63, a market capitalization of $2.3 billion.
- Return on equity was −18.0% and debt-to-equity 0.96.
Coty (COTY) Latest News
24 Sep
StockStory flags three value stocks it believes have limited support: Coty (COTY), CONMED (CNMD), and OceanFirst Financial (OCFC). Coty, priced around $2.63 with a forward P/E of 8.4x, is seen as underperforming as organic revenue has lagged for two years, with a forecasted 1.2% revenue drop for the next 12 months and a 26.6% annual EPS decline tied to new share issuances. The piece warns Coty could be a value trap and contrasts it with “better opportunities.” CNMD and OCFC are similarly looked at critically (CNMD with weak constant-currency growth; OCFC with slow net interest income growth and declining tangible book value). Free reports accompany the analysis. Declining organic revenue plus a forecast revenue drop and EPS dilution from share issuances signal a moderately negative trajectory.
23 Sep
Coty Inc. reported stronger results in its Americas business for fiscal Q4 2026. Net revenues rose 9% year over year to $554.7 million, while like-for-like sales grew 6%, aided in part by immaterial Argentina price effects from hyperinflation. Growth came mainly from the United States, Brazil and Travel Retail, with Canada weighing on the region. In the US, demand exceeded expectations across prestige fragrances and mass cosmetics, and sell-out trends for Consumer Beauty improved, led by Sally Hansen and CoverGirl. Sally Hansen US value sales rose 5% in the latest four weeks, narrowing the gap to category growth; CoverGirl swung to slight growth as unit declines narrowed. For fiscal 2026, Coty Americas revenue totaled $2.34 billion, down 1% on a reported basis and 3% LFL, while the full year saw a modest LFL decline. Americas LFL up 6% in Q4 and US-led strength hint at modest near-term improvement without reversing the full-year decline.
21 Sep
Coty is singled out as a stock to sell due to volatility and weak fundamentals: core business growth has stalled, organic revenue declined for two straight years, and EPS fell about 26.6% yearly; next 12 months’ revenue is forecast to drop around 1.2%. At roughly $2.44, the stock trades near 7.7x forward P/E with a rolling one-year beta of 1.45, signaling elevated risk and the possibility that acquisitions may be needed to rekindle growth. Core underperformance and potential growth pivots imply meaningful downside risk and strategic shifts.
20 Sep
Coty enters a transition year with valuation remaining a central investor concern amid shifting market dynamics. Transition year and valuation focus point to moderate effects on Coty's financial trajectory and sentiment.
19 Sep
Blackstone's stake in ZO Skin Health could value the skincare brand at $2 billion outside Sephora retail channels. Potential $2 billion valuation of ZO Skin Health signals rising competition in premium skincare affecting Coty's positioning.
28 Aug
Coty reports weak quarterly profit and withholds annual forecasts, describing the period as a transition year. Weak profit and withheld forecasts create uncertainty likely to pressure stock performance and investor sentiment.
26 Aug
Coty held its Q2 earnings call and addressed the top 5 analyst questions on results and strategy. Q2 earnings call details and analyst questions offer moderate insights into Coty's performance and outlook.
25 Aug
Coty shares declined as questions arise over whether its transition year conceals deeper issues in the product portfolio. Portfolio concerns could affect Coty's growth trajectory and investor sentiment without fundamentally altering operations.
24 Aug
Coty generates substantial revenue from international markets, highlighting dependence on overseas sales amid varying regional economic conditions. Heavy international revenue exposure creates measurable risks from currency shifts and regional demand changes for Coty.
21 Aug
Coty projects 2026 losses, exits Gucci partnership and names new CFO, altering investor views on operations and outlook. Projected losses, Gucci exit and new CFO appointment represent major strategic and leadership shifts likely to reshape Coty's trajectory.
20 Aug
Coty Inc reports Q4 2026 earnings with focus on strategic turnaround and exit from Gucci partnership that reshapes future operations and brand portfolio. Gucci exit combined with turnaround strategy represents major shift likely to alter Coty trajectory and investor views.
Coty focuses on market share strategy and brand simplification in Q2 while confronting margin pressures. Brand simplification efforts and margin pressures point to moderate effects on Coty's operations and positioning.
Coty targets portfolio growth by 2028 via innovation and brand investment during Gucci license transition. Long-term growth targets and license shift indicate moderate influence on operations and positioning.
Coty posted a wider-than-expected Q4 loss while Prestige segment revenues rose 1%. Mixed Q4 earnings with wider loss and modest segment growth point to limited near-term effects on Coty trajectory.
Coty stock fell sharply after reporting weaker-than-expected quarterly sales and cutting full-year guidance, driven by soft demand in its consumer beauty division and ongoing supply-chain constraints. Lowered guidance and soft sales point to near-term pressure on revenue and margins but do not indicate structural change to Coty's long-term position.
Coty Q4 earnings call highlights financial results, revenue figures, segment performance and management outlook on growth initiatives and margins. Q4 earnings details provide updates on revenue and outlook that may sway near-term investor sentiment without major strategic shifts.
Coty stock falls after RBC downgrade and lack of forward visibility overshadow Q4 earnings beat. RBC downgrade and visibility shortfall create moderate pressure on near-term sentiment and performance.
Coty Inc. held its Q4 2026 earnings call covering financial results, performance metrics, and forward outlook. Quarterly earnings calls typically provide moderate updates on financials and guidance that can shift near-term sentiment.
Coty shares declined after Q4 revenue beat expectations, as weak FY27 visibility weighed on investor sentiment and overshadowed the results. Weak FY27 visibility creates moderate uncertainty around Coty's long-term growth and market trajectory.
Coty stock fell 6% overnight after the company flagged a transition year ahead. Transition year signal and resulting stock drop point to moderate near-term effects on operations and sentiment.
Coty Inc highlighted strategic transition initiatives and progress on debt reduction during its Q4 2026 earnings call. Strategic transition and debt reduction represent targeted financial and operational adjustments with moderate long-term effects on stability and growth.
19 Aug
Coty (COTY) posts earnings that test the narrative of the stock being undervalued. Earnings results directly affect Coty valuation assessments and investor sentiment.
Coty Q4 earnings call highlights include financial results, segment performance and management outlook on operations and guidance. Quarterly earnings updates affect near-term financial views and sentiment but rarely shift long-term company trajectory.
Coty concludes fiscal year with positive sales despite Gucci license loss and appoints new CFO to drive next growth phase. Positive sales close fiscal year while Gucci license loss and new CFO appointment indicate moderate operational and leadership shifts without major trajectory change.
Coty's Q2 CY2026 sales beat estimates yet its stock declined after the report. Sales beat offset by stock drop signals moderate influence on near-term sentiment and outlook.
Coty announces fourth quarter fiscal year 2026 results. Quarterly results release delivers financial metrics that can shift near-term stock sentiment but rarely redefine company strategy.
14 Aug
Coty (COTY) is scheduled to report Q4 earnings, delivering key financial results and outlook details for investors. Q4 earnings release can moderately shift Coty stock price and near-term investor views on performance.
11 Jul
Luxury retailer exits beauty business and ends major partnership with Coty. Loss of major partnership reduces Coty's revenue and market presence.
9 Jul
Coty Inc (COTY) announces major organizational changes to accelerate its Coty.Curated Strategy. Major organizational restructuring represents strategic moves expected to significantly alter company trajectory and investor sentiment.
8 Jul
Gucci Beauty license shifts from Coty to L’Oréal, triggering analyst reviews of revenue loss and strategic setbacks for Coty’s beauty portfolio and market position. Loss of Gucci Beauty license directly removes major revenue stream and brand equity from Coty.